Bibliography
- Engelgau MM , GeissLS, SaaddineJBet al.: The evolving diabetes burden in the United States.Ann. Intern. Med.140, 945–950(2004).
- Vijan S , HaywardRA: Treatment of hypertension in Type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.Ann. Intern. Med.138, 593–602(2003).
- Vijan S , HaywardRA: Pharmacologic lipid-lowering therapy in Type 2 diabetes mellitus: background paper for the American College of Physicians.Ann. Intern. Med.140, 650–658(2004).
- Stratton IM , AdlerAI, NeilAWet al.: Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study.Br. Med. J.321, 405–412(2000).
- UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes (UKPDS 34). Lancet352, 854–865(1998).
- The Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in Type 2 diabetes. N. Engl. J. Med.358, 2545–2559(2008).
- The ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with Type 2 diabetes. N. Engl. J. Med.358, 2560–2572(2008).
- Kirkman MS , McCarrenM, ShahJ, DuckworthW, Abraira C; VADT Study Group: The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes. J. Diabetes Complications20, 7580 (2006).
- Gaede P , VedelP, LarsenN, JensenGV, ParvingHH, PedersenO: Multifactorial intervention and cardiovascular disease in patients with Type 2 diabetes.N. Engl. J. Med.348, 383–393(2003).
- Gaede P , Lund-AndersenH, ParvingHH, PedersenO: Effect of a multifactorial intervention on mortality in Type 2 diabetes.N. Engl. J. Med.358, 580–591(2008).
Website
- American Diabetes Association 68th Scientific Sessions. http://professional.diabetes.org/Congress_Display.aspx?TYP=9&SID=90&CID=60976 (Accessed June8, 2008)